Summary
Headquartered in Chalfont St. Giles, UK, GE Healthcare is a global leader in medical imaging, healthcare IT, diagnostic imaging agents, patient monitoring, drug discovery and protein separation. GE Healthcare also offers services to improve productivity and enable healthcare providers to better diagnose, treat and manage patients. The company employs over 43,000 people in over 100 countries and is a subsidiary of General Electric, one of the largest and most diversified companies in the world.
In fiscal 2005, GE Healthcare achieved revenue growth of 13% to US$15.2 billion, led by the benefits of the acquisitions of Amersham in 2004 and Instrumentarium in 2003, while operating profit rose by 17% to US$2.7 billion.
GE Healthcare comprises two main entities: GE Healthcare Technologies (formerly GE Medical Systems) and GE Healthcare Bio-Sciences (formerly Amersham). Approximately 80% of GE Healthcare's revenue was generated by GE Healthcare Technologies in 2005, with the remainder from GE Healthcare Bio-Sciences.
Headquartered in Waukesha, Wisconsin, USA, GE Healthcare Technologies is a US$12.1 billion business that provides a broad portfolio of medical imaging and information technologies, patient monitoring systems and healthcare services. The business was expanded in January 2006 through the acquisition of IDX Systems, a leading healthcare IT provider. As a result of the transaction, GE Healthcare's IT business has been renamed GE Healthcare Integrated IT Solutions.
Headquartered in Little Chalfont, UK, GE Healthcare Bio-Sciences is a US$3 billion business that provides diagnostic imaging agents, drug discovery and protein separation systems. In 2005, sales of medical diagnostic products totalled US$1.8 billion and US$1.2 billion came from life science products.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
|
